[HTML] springer.comFull View

[HTML][HTML] Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor

JE Hwang, JY Yoon, WK Bae, HJ Shim, SH Cho… - BMC cancer, 2010 - Springer
Background Imatinib mesylate has been used for the treatment of unresectable or metastatic
gastrointestinal stromal tumors (GIST). The current recommended dose of imatinib is 400 …
被引用次数：21 相关文章

Imatinib induced severe skin reactions andneutropenia in a patient with gastrointestinalstromal tumor.

JE Hwang, JY Yoon, WK Bae, HJ Shim… - BMC …, 2010 - search.ebscohost.com
Background: Imatinib mesylate has been used for the treatment of unresectable or
metastatic gastrointestinal stromal tumors (GIST). The current recommended dose of …

Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor

JE Hwang, JY Yoon, WK Bae, HJ Shim, SH Cho… - BMC cancer …, 2010 - inis.iaea.org
[en] Imatinib mesylate has been used for the treatment of unresectable or metastatic
gastrointestinal stromal tumors (GIST). The current recommended dose of imatinib is 400 …

Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor

JE Hwang, JY Yoon, WK Bae, HJ Shim, SH Cho… - BMC …, 2010 - search.proquest.com
Background: Imatinib mesylate has been used for the treatment of unresectable or
metastatic gastrointestinal stromal tumors (GIST). The current recommended dose of …
[HTML] osti.gov

[HTML][HTML] Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor

JE Hwang, JY Yoon, WK Bae, HJ Shim, SH Cho… - BMC cancer (Online …, 2010 - osti.gov
Imatinib mesylate has been used for the treatment of unresectable or metastatic
gastrointestinal stromal tumors (GIST). The current recommended dose of imatinib is 400 …

Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor.

JE Hwang, JY Yoon, WK Bae, HJ Shim, SH Cho… - BMC Cancer, 2010 - europepmc.org
Background Imatinib mesylate has been used for the treatment of unresectable or metastatic
gastrointestinal stromal tumors (GIST). The current recommended dose of imatinib is 400 …

Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor

JE Hwang, JY Yoon, WK Bae, HJ Shim… - BMC …, 2010 - pubmed.ncbi.nlm.nih.gov
Background Imatinib mesylate has been used for the treatment of unresectable or metastatic
gastrointestinal stromal tumors (GIST). The current recommended dose of imatinib is 400 …
[PDF] psu.edu

[PDF][PDF] Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor

JE Hwang, JY Yoon, WK Bae, HJ Shim, SH Cho… - 2010 - Citeseer
Background: Imatinib mesylate has been used for the treatment of unresectable or
metastatic gastrointestinal stromal tumors (GIST). The current recommended dose of …
[HTML] nih.gov

[HTML][HTML] Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor

JE Hwang, JY Yoon, WK Bae, HJ Shim, SH Cho… - BMC Cancer, 2010 - ncbi.nlm.nih.gov
Background Imatinib mesylate has been used for the treatment of unresectable or metastatic
gastrointestinal stromal tumors (GIST). The current recommended dose of imatinib is 400 …
[PDF] cyberleninka.org

[PDF][PDF] Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor

JE Hwang, JY Yoon, WK Bae, HJ Shim, SH Cho… - 2010 - cyberleninka.org
Background: Imatinib mesylate has been used for the treatment of unresectable or
metastatic gastrointestinal stromal tumors (GIST). The current recommended dose of …